Ameriprise
KITE

Ameriprise’s Kite Pharma, Inc. KITE Stock Holding History

Ameriprise’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,209
Closed -$1.84M – 3821
2017
Q3 		$1.84M Sell
10,209
-72,261
-88% -$10.1M ﹤0.01% 2658
2017
Q2 		$8.55M Sell
82,470
-31,913
-28% -$2.6M ﹤0.01% 1684
2017
Q1 		$8.98M Buy
114,383
+19,553
+21% +$1.21M ﹤0.01% 1612
2016
Q4 		$4.25M Buy
94,830
+10,489
+12% +$515K ﹤0.01% 2156
2016
Q3 		$4.71M Buy
84,341
+51,112
+154% +$2.85M ﹤0.01% 2043
2016
Q2 		$1.66M Sell
33,229
-6,640
-17% -$326K ﹤0.01% 2621
2016
Q1 		$1.83M Sell
39,869
-1,641
-4% -$79.5K ﹤0.01% 2553
2015
Q4 		$2.56M Buy
41,510
+27,438
+195% +$1.93M ﹤0.01% 2456
2015
Q3 		$784K Sell
14,072
-35,377
-72% -$2.23M ﹤0.01% 3082
2015
Q2 		$3.01M Buy
+49,449
New +$2.82M ﹤0.01% 2495
2015
Q1 		– Sell
-34,263
Closed -$1.98M – 3975
2014
Q4 		$1.98M Buy
+34,263
New +$1.44M ﹤0.01% 2567

Ameriprise's KITE Position: Q4 2017 in Review

Ameriprise sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 10,209 shares — an estimated $1.84M sold.

Ameriprise first reported a position in KITE in Q4 2014 and held it in 11 quarters. The position peaked at $8.98M in Q1 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Ameriprise reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Ameriprise sold 10,209 Kite Pharma, Inc. shares in Q4 2017, an estimated $1.84M.
  • Ameriprise first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 11 quarters.
  • Ameriprise's Kite Pharma, Inc. position peaked at $8.98M in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Ameriprise's 13F filing for Q4 2017, filed 12 Feb 2018.